After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
"We need to pass legislation that ensures patients have better access to FDA-approved, non-opioid pain management ...
Philly’s opioid addiction crisis is constantly evolving. Local health care workers and researchers explain some of the latest ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Some lawmakers said they want the public’s help in deterring major drug traffickers from continually selling drugs in West ...
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
A 40-foot large consignment of opioid-based pain relief medications containing dosages that far exceed the approved limits ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
Millions are turning to an unregulated herbal extract to curb their opioid addiction. But do the risks outweigh the benefits?